- Home
- ETON vs FLYX Comparison
ETON vs FLYX Comparison
Compare ETON & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- FLYX
- Stock Information
- Founded
- ETON 2017
- FLYX 2015
- Country
- ETON United States
- FLYX United States
- Employees
- ETON N/A
- FLYX N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- FLYX Blank Checks
- Sector
- ETON Health Care
- FLYX Finance
- Exchange
- ETON Nasdaq
- FLYX Nasdaq
- Market Cap
- ETON 329.8M
- FLYX 264.1M
- IPO Year
- ETON 2018
- FLYX N/A
- Fundamental
- Price
- ETON $14.55
- FLYX $3.10
- Analyst Decision
- ETON Strong Buy
- FLYX
- Analyst Count
- ETON 3
- FLYX 0
- Target Price
- ETON $27.67
- FLYX N/A
- AVG Volume (30 Days)
- ETON 235.8K
- FLYX 8.9K
- Earning Date
- ETON 05-08-2025
- FLYX 01-01-0001
- Dividend Yield
- ETON N/A
- FLYX N/A
- EPS Growth
- ETON N/A
- FLYX N/A
- EPS
- ETON N/A
- FLYX N/A
- Revenue
- ETON $39,011,000.00
- FLYX $327,274,000.00
- Revenue This Year
- ETON $92.33
- FLYX $35.08
- Revenue Next Year
- ETON $52.62
- FLYX N/A
- P/E Ratio
- ETON N/A
- FLYX N/A
- Revenue Growth
- ETON 23.29
- FLYX 3.78
- 52 Week Low
- ETON $3.11
- FLYX $1.79
- 52 Week High
- ETON $18.41
- FLYX $8.39
- Technical
- Relative Strength Index (RSI)
- ETON 57.21
- FLYX 49.99
- Support Level
- ETON $13.53
- FLYX $2.95
- Resistance Level
- ETON $14.40
- FLYX $3.19
- Average True Range (ATR)
- ETON 0.97
- FLYX 0.18
- MACD
- ETON 0.32
- FLYX 0.01
- Stochastic Oscillator
- ETON 96.19
- FLYX 57.58
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.